Who owns Citius Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CTXR from SEC Form 13F filings across 43 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 43 institutions disclosed 1.4M shares of Citius Pharmaceuticals, Inc. worth $810,022 — about 5.2% of shares outstanding; the largest disclosed holder is GEODE CAPITAL MANAGEMENT, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
43
13F holders
$810,022
value, 2026 filers
5.2%
of shares outstanding (1.4M sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CTXR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 215,537 | $130,302 | 0.0% | 0.8% | -12.4% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 197,364 | $119,405 | 0.0% | 0.8% | +17.7% |
| 3 | Miller Financial Services LLC | 130,000 | $78,585 | 0.1% | 0.5% | +828.6% |
| 4 | CITADEL ADVISORS LLCNEW | 124,910 | $75,508 | 0.0% | 0.5% | new |
| 5 | JANE STREET GROUP, LLC | 122,837 | $74,255 | 0.0% | 0.5% | +445.4% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 77,755 | $47,042 | 0.0% | 0.3% | 0.0% |
| 7 | BlackRock, Inc. | 69,850 | $42,224 | 0.0% | 0.3% | 0.0% |
| 8 | NORTHERN TRUST CORP | 62,742 | $37,928 | 0.0% | 0.2% | +42.7% |
| 9 | XTX Topco Ltd | 59,199 | $35,786 | 0.0% | 0.2% | +178.0% |
| 10 | Asset Advisory Group, Inc. | 59,011 | $35,672 | 0.0% | 0.2% | 0.0% |
| 11 | BostonPremier Wealth LLCNEW | 28,000 | $16,926 | 0.0% | 0.1% | new |
| 12 | UBS Group AG | 26,335 | $15,933 | 0.0% | 0.1% | -52.1% |
| 13 | LPL Financial LLC | 25,445 | $15,381 | 0.0% | 0.1% | +1.6% |
| 14 | STATE STREET CORP | 23,271 | $14,067 | 0.0% | 0.1% | 0.0% |
| 15 | Virtu Financial LLCNEW | 20,836 | $13 | 0.0% | 0.1% | new |
| 16 | Arkadios Wealth Advisors | 20,000 | $12,090 | 0.0% | 0.1% | 0.0% |
| 17 | TWO SIGMA INVESTMENTS, LP | 17,494 | $10,575 | 0.0% | 0.1% | +33.2% |
| 18 | Sanctuary Advisors, LLCNEW | 11,810 | $7,139 | 0.0% | 0% | new |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,795 | $7,130 | 0.0% | 0% | -68.0% |
| 20 | R Squared LtdNEW | 11,033 | $6,670 | 0.0% | 0% | new |
| 21 | TWO SIGMA SECURITIES, LLCNEW | 10,006 | $6,049 | 0.0% | 0% | new |
| 22 | SBI Securities Co., Ltd. | 9,519 | $5,754 | 0.0% | 0% | +46.0% |
| 23 | CHELSEA COUNSEL CO | 4,626 | $2,797 | 0.0% | 0% | 0.0% |
| 24 | Quent Capital, LLC | 4,232 | $2,558 | 0.0% | 0% | -0.8% |
| 25 | IFP Advisors, Inc | 4,183 | $2,529 | 0.0% | 0% | -40.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.